Late Relapse of Diabetes After Bariatric Surgery: Not Rare, but Not a Failure
Open accessThe DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To characterize the status of cardiometabolic risk factors after late relapse of type 2 diabetes mellitus (T2DM) and to identify factors predicting relapse after initial diabetes remission following bariatric surgery to construct prediction models for clinical practice. RESEARCH DESIGN AND METHODS: Outcomes of 736 patients with T2DM who underwent Roux-en-Y gastric bypass (RYGB) or sleeve gastrectomy (SG) at an academic center (2004–2012) and had ≥5 years’ glycemic follow-up were assessed. Of 736 patients, 425 (58%) experienced diabetes remission (HbA1c <6.5% [48 mmol/mol] with patients off medications) in the 1st year after surgery. These 425 patients were followed for a median of 8 years (range 5–14) to characterize late relapse of diabetes. RESULTS: In 136 (32%) patients who experienced late relapse, a statistically significant improvement in glycemic control, number of diabetes medications including insulin use, blood pressure, and lipid profile was still observed at long-term. Independent baseline predictors of late relapse were preoperative number of diabetes medications, duration of T2DM before surgery, and SG versus RYGB. Furthermore, patients who relapsed lost less weight during the 1st year after surgery and regained more weight afterward. Prediction models were constructed and externally validated. CONCLUSIONS: While late relapse of T2DM is a real phenomenon (one-third of our cohort), it should not be considered a failure, as the trajectory of the disease and its related cardiometabolic risk factors is changed favorably after bariatric surgery. Earlier surgical intervention, RYGB (compared with SG) and more weight loss (less late weight regain) are associated with less diabetes relapse in the long-term.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“As a consequence, patients may only experience partial remission of comorbidities; e.g., a large number of patients who experience complete T2D remission in the early period after surgery suffer a relapse on long-term follow-up [4].”
Citations
Cites
Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 5-Year Outcomes
Schauer, P. R., Bhatt, D. L., Kirwan, J. P., Wolski, K., Aminian, A., Brethauer, S. A., Navaneethan, S. D., Singh, R. P., Pothier, C. E., Nissen, S. E., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1600869 · Cited by 2,934 · cited 1×
“not at this target 5 years after surgery (9).”
BackgroundSelf-citationSjöström, L. (2013) · Journal of Internal Medicine · doi:10.1111/joim.12012 · Cited by 1,835 · cited 1×
“In the Swedish Obese Subjects (SOS) study, of 342 patients with T2DM before bariatric surgery, 72% experienced diabetes remission at 2 years after surgery but only 36% remained diabetes free at 10-year follow-up (50% relapse rate) (10,22).”
BackgroundMingrone, G., Panunzi, S., De Gaetano, A., Guidone, C., Iaconelli, A., Nanni, G., Castagneto, M., Bornstein, S., & Rubino, F. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00075-6 · Cited by 1,220
Sjöström, L., Peltonen, M., Jacobson, P., Ahlin, S., Andersson-Assarsson, J., Anveden, Å., Bouchard, C., Carlsson, B., Karason, K., Lönroth, H., et al. (2014) · JAMA · doi:10.1001/jama.2014.5988 · Cited by 1,054 · cited 1×
“In the Swedish Obese Subjects (SOS) study, of 342 patients with T2DM before bariatric surgery, 72% experienced diabetes remission at 2 years after surgery but only 36% remained diabetes free at 10-year follow-up (50% relapse rate) (10,22).”
BackgroundIFSO Worldwide Survey 2016: Primary, Endoluminal, and Revisional Procedures
Angrisani, L., Santonicola, A., Iovino, P., Vitiello, A., Higa, K., Himpens, J., Buchwald, H., & Scopinaro, N. (2018) · Obesity Surgery · doi:10.1007/s11695-018-3450-2 · Cited by 1,032 · cited 1×
“95% of the primary bariatric procedures worldwide in patients with T2DM (33,34) means that the findings of this study will be relevant to the practice of most of the bariatric surgeons globally.”
BackgroundHow do we define cure of diabetes?
Buse, J. B., Caprio, S., Cefalu, W. T., Ceriello, A., Del Prato, S., Inzucchi, S. E., McLaughlin, S., Phillips, G. L., Robertson, R. P., Rubino, F., et al. (2009) · Diabetes Care · doi:10.2337/dc09-9036 · Cited by 1,003 · cited 4×
“© 2020 by the American Diabetes Association.”
MethodInfluentialSalminen, P., Helmiö, M., Ovaska, J., Juuti, A., Leivonen, M., Peromaa-Haavisto, P., Hurme, S., Soinio, M., Nuutila, P., & Victorzon, M. (2018) · JAMA · doi:10.1001/jama.2017.20313 · Cited by 946 · cited 1×
“1) Hospital Cĺınic de Barcelona, 2) patients with T2DM who were enrolled in the Sleeve vs Bypass (SLEEVEPASS) randomized clinical trial (16) from Finland, and 3) patients from Geisinger Clinic in Danville, PA.”
MethodSelf-citationStandardized outcomes reporting in metabolic and bariatric surgery
Brethauer, S. A., Kim, J., el Chaar, M., Papasavas, P., Eisenberg, D., Rogers, A., Ballem, N., Kligman, M., & Kothari, S. (2015) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2015.02.003 · Cited by 944
Self-citationBrethauer, S. A., Aminian, A., Romero-Talamás, H., Batayyah, E., Mackey, J., Kennedy, L., Kashyap, S. R., Kirwan, J. P., Rogula, T., Kroh, M., et al. (2013) · Annals of Surgery · doi:10.1097/sla.0b013e3182a5034b · Cited by 552
Self-citationAminian, A., Zajichek, A., Arterburn, D. E., Wolski, K. E., Brethauer, S. A., Schauer, P. R., Kattan, M. W., & Nissen, S. E. (2019) · JAMA · doi:10.1001/jama.2019.14231 · Cited by 505
Self-citationArterburn, D. E., Bogart, A., Sherwood, N. E., Sidney, S., Coleman, K. J., Haneuse, S., O’Connor, P. J., Theis, M. K., Campos, G. M., McCulloch, D., et al. (2013) · Obesity Surgery · doi:10.1007/s11695-012-0802-1 · Cited by 426 · cited 2×
“gest that those with poor preoperative diabetes control, those with longer duration of T2DM, and those requiring insulin at the time of surgerydthe clinical factors indicating diminished pancreatic b-cell reservedare less likely to experience durable long-term remission (7,8,13).”
BackgroundPotential of Surgery for Curing Type 2 Diabetes Mellitus
Rubino, F., & Gagner, M. (2002) · Annals of Surgery · doi:10.1097/00000658-200211000-00003 · Cited by 374 · cited 1×
“surgery might offer a permanent cure (2) for T2DM have had to be moderated as it became apparent that not all patients with T2DM experience a remission with bariatric surgery (3,4) and that a large number of those who experience a remission in the early period after surgery suffer a relapse on longer-term”
BackgroundStandardized Outcomes Reporting in Metabolic and Bariatric Surgery
for the ASMBS Clinical Issues Committee, Brethauer, S. A., Kim, J., el Chaar, M., Papasavas, P., Eisenberg, D., Rogers, A., Ballem, N., Kligman, M., & Kothari, S. (2015) · Obesity Surgery · doi:10.1007/s11695-015-1645-3 · Cited by 288
Self-citationRe-emergence of diabetes after gastric bypass in patients with mid- to long-term follow-up
DiGiorgi, M., Rosen, D. J., Choi, J. J., Milone, L., Schrope, B., Olivero-Rivera, L., Restuccia, N., Yuen, S., Fisk, M., Inabnet, W. B., et al. (2010) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2009.09.019 · Cited by 282
Individualized Metabolic Surgery Score: Procedure Selection Based on Diabetes Severity
Aminian, A., Brethauer, S. A., Andalib, A., Nowacki, A. S., Jimenez, A., Corcelles, R., Hanipah, Z. N., Punchai, S., Bhatt, D. L., Kashyap, S. R., et al. (2017) · Annals of Surgery · doi:10.1097/sla.0000000000002407 · Cited by 256 · cited 1×
“The most frequently identified predictors of relapse in the scientific literature were signs of advanced T2DMat the time of surgery (23,24).”
BackgroundSelf-citationJiménez, A., Casamitjana, R., Flores, L., Viaplana, J., Corcelles, R., Lacy, A., & Vidal, J. (2012) · Annals of Surgery · doi:10.1097/sla.0b013e318262ee6b · Cited by 237 · cited 1×
“(25,26), those experiencing a relapse had poorer b-cell function in comparison with those maintaining a durable remission.”
BackgroundSelf-citationAnalysis of factors associated with durable remission of diabetes after Roux-en-Y gastric bypass
Chikunguwo, S. M., Wolfe, L. G., Dodson, P., Meador, J. G., Baugh, N., Clore, J. N., Kellum, J. M., & Maher, J. W. (2010) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2009.11.003 · Cited by 227 · cited 1×
“(19) observed that T2DM recurred orworsened frompeak benefits in;24% and 43% of their patients, respectively.”
BackgroundTrends in utilization of bariatric surgery, 2010-2014: sleeve gastrectomy dominates
Khorgami, Z., Shoar, S., Andalib, A., Aminian, A., Brethauer, S. A., & Schauer, P. R. (2017) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2017.01.031 · Cited by 211 · cited 1×
“95% of the primary bariatric procedures worldwide in patients with T2DM (33,34) means that the findings of this study will be relevant to the practice of most of the bariatric surgeons globally.”
BackgroundSelf-citationO'Brien, R., Johnson, E., Haneuse, S., Coleman, K. J., O'Connor, P. J., Fisher, D. P., Sidney, S., Bogart, A., Theis, M. K., Anau, J., et al. (2018) · Annals of Internal Medicine · doi:10.7326/m17-2383 · Cited by 161 · cited 1×
“Therefore, it is possible that patientswho eventually relapse with T2DM after bariatric surgery will still continue to experience reduced micro- and macrovascular complications in the long-term(3,29,30).”
BackgroundRubino, F., Nathan, D. M., Eckel, R. H., Schauer, P. R., Alberti, K. G. M. M., Zimmet, P. Z., Del Prato, S., Ji, L., Sadikot, S. M., Herman, W. H., et al. (2016) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2016.05.018 · Cited by 157
Self-citationValidation in prediction research: the waste by data splitting
Steyerberg, E. W. (2018) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2018.07.010 · Cited by 156 · cited 2×
“, diabetes relapse) (17), data of three cohorts were combined to prevent possible overestimation of model per-”
BackgroundDebédat, J., Sokolovska, N., Coupaye, M., Panunzi, S., Chakaroun, R., Genser, L., de Turenne, G., Bouillot, J.-L., Poitou, C., Oppert, J.-M., et al. (2018) · Diabetes Care · doi:10.2337/dc18-0567 · Cited by 138
Carlsson, L. M. S., Sjöholm, K., Karlsson, C., Jacobson, P., Andersson-Assarsson, J. C., Svensson, P.-A., Larsson, I., Hjorth, S., Neovius, M., Taube, M., et al. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30061-x · Cited by 126 · cited 1×
“Therefore, it is possible that patientswho eventually relapse with T2DM after bariatric surgery will still continue to experience reduced micro- and macrovascular complications in the long-term(3,29,30).”
BackgroundMadsen, L. R., Baggesen, L. M., Richelsen, B., & Thomsen, R. W. (2019) · Diabetologia · doi:10.1007/s00125-019-4816-2 · Cited by 125 · cited 1×
“Furthermore, the possible benefit from the legacy effect of improved glycemic control provides support to look at these long-term results in a positive light (3,32).”
BackgroundAminian, A., Brethauer, S. A., Andalib, A., Punchai, S., Mackey, J., Rodriguez, J., Rogula, T., Kroh, M., & Schauer, P. R. (2016) · Annals of Surgery · doi:10.1097/sla.0000000000001857 · Cited by 113 · cited 1×
“surgery might offer a permanent cure (2) for T2DM have had to be moderated as it became apparent that not all patients with T2DM experience a remission with bariatric surgery (3,4) and that a large number of those who experience a remission in the early period after surgery suffer a relapse on longer-term”
BackgroundSelf-citationColeman, K. J., Haneuse, S., Johnson, E., Bogart, A., Fisher, D., O’Connor, P. J., Sherwood, N. E., Sidney, S., Theis, M. K., Anau, J., et al. (2016) · Diabetes Care · doi:10.2337/dc16-0194 · Cited by 107 · cited 1×
“(31) studied 4,683 patients with T2DMwho had undergone bariatric surgery in four”
BackgroundExploring the impact of bariatric surgery on high density lipoprotein
Aminian, A., Zelisko, A., Kirwan, J. P., Brethauer, S. A., & Schauer, P. R. (2014) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2014.07.017 · Cited by 86
Self-citationLegacy Effects from DCCT and UKPDS: What They Mean and Implications for Future Diabetes Trials
Murray, P. T., Chune, G., & Raghavan, V. A. (2010) · Current Atherosclerosis Reports · doi:10.1007/s11883-010-0128-1 · Cited by 79 · cited 1×
“beneficial effect of time spent with better control of diabetes on long-term complications, irrespective of diabetes control on long-term follow-up, has variously been described as the “legacy effect” or “metabolicmemory” (3,28).”
BackgroundJiménez, A., Casamitjana, R., Flores, L., Delgado, S., Lacy, A. M., & Vidal, J. (2012) · Annals of Surgery · doi:10.1097/sla.0b013e31826b8603 · Cited by 65 · cited 1×
“(25,26), those experiencing a relapse had poorer b-cell function in comparison with those maintaining a durable remission.”
BackgroundSelf-citationAminian, A., Brethauer, S. A., Daigle, C. R., Kirwan, J. P., Burguera, B. G., Kashyap, S. R., & Schauer, P. R. (2014) · Acta Diabetologica · doi:10.1007/s00592-014-0642-7 · Cited by 20 · cited 1×
“The most frequently identified predictors of relapse in the scientific literature were signs of advanced T2DMat the time of surgery (23,24).”
BackgroundSelf-citationAdami, G. F., Camerini, G. B., Papadia, F. S., Catalano, M., Carlini, F., Cordera, R., & Scopinaro, N. (2018) · Obesity Surgery · doi:10.1007/s11695-018-3511-6 · Cited by 19
Refractory and new-onset diabetes more than 5 years after gastric bypass for morbid obesity
Yamaguchi, C. M., Faintuch, J., Hayashi, S. Y., Faintuch, J. J., & Cecconello, I. (2012) · Surgical Endoscopy · doi:10.1007/s00464-012-2256-x · Cited by 18 · cited 1×
“New-onset T2DM after bariatric surgery has also been reported (20,21) in the scientific literature.”
BackgroundSleeve Gastrectomy and Diabetes
Andalib, A., & Aminian, A. (2017) · Advances in Surgery · doi:10.1016/j.yasu.2017.03.003 · Cited by 18 · cited 1×
“gest that those with poor preoperative diabetes control, those with longer duration of T2DM, and those requiring insulin at the time of surgerydthe clinical factors indicating diminished pancreatic b-cell reservedare less likely to experience durable long-term remission (7,8,13).”
BackgroundSelf-citationDevelopment of De Novo Diabetes in Long-Term Follow-up After Bariatric Surgery
Hanipah, Z. N., Punchai, S., Brethauer, S. A., Schauer, P. R., & Aminian, A. (2018) · Obesity Surgery · doi:10.1007/s11695-018-3194-z · Cited by 5 · cited 1×
“New-onset T2DM after bariatric surgery has also been reported (20,21) in the scientific literature.”
BackgroundSelf-citation
Cited by
Salminen, P., Grönroos, S., Helmiö, M., Hurme, S., Juuti, A., Juusela, R., Peromaa-Haavisto, P., Leivonen, M., Nuutila, P., & Ovaska, J. (2022) · JAMA Surgery · doi:10.1001/jamasurg.2022.2229 · Cited by 456
Self-citationObesity as a multisystem disease: Trends in obesity rates and obesity‐related complications
Sarma, S., Sockalingam, S., & Dash, S. (2021) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14290 · Cited by 435
“It can cause long-term remission of T2D in ~30% of patients, with the majority of patients experiencing improved glycaemia.(51)”
BackgroundBlüher, M. (2025) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.16263 · Cited by 175
Lautenbach, A., Wernecke, M., Huber, T. B., Stoll, F., Wagner, J., Meyhöfer, S. M., Meyhöfer, S., & Aberle, J. (2022) · Obesity Surgery · doi:10.1007/s11695-022-06211-9 · Cited by 92
Roux-en-Y Gastric Bypass vs Sleeve Gastrectomy for Remission of Type 2 Diabetes
Castellana, M., Procino, F., Biacchi, E., Zupo, R., Lampignano, L., Castellana, F., Sardone, R., Palermo, A., Cesareo, R., Trimboli, P., et al. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa737 · Cited by 74
Metadata
- Authors
- Aminian, A., Vidal, J., Salminen, P., Still, C. D., Nor Hanipah, Z., Sharma, G., Tu, C., Wood, G. C., Ibarzabal, A., Jimenez, A., Brethauer, S. A., Schauer, P. R., & Mahawar, K.
- Affiliations
- Cleveland Clinic (US)
- Obesity Unit, Hospital Clínic de Barcelona, Barcelona, Spain
- University of Turku (FI)
- Geisinger Medical Center (US)
- Bariatric and Metabolic Institute, Department of General Surgery, Cleveland Clinic, Cleveland, OH
- Pennington Biomedical Research Center (US)
- Sunderland Royal Hospital (GB)
- Corresponding author
- Aminian, Ali
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2020-01-23
- Volume
- 43
- Issue
- 3
- Pages
- 534-540
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W3001053202
- Cited by
- 122
- References
- 34
- Citations by year
- 2026: 8 · 2025: 19 · 2024: 14 · 2023: 18 · 2022: 21 · 2021: 28 · 2020: 14
- FWCI
- 18.51
- Type
- journal article
- Language
- en
- Open access
- green
- psasir.upm.edu.my
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Universiti Putra Malaysia Institutional Repository (Universiti Putra Malaysia) (submittedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- type 2 diabetes, bariatric surgery, late recurrence, diabetes remission, Roux-en-Y gastric bypass, sleeve gastrectomy, weight regain, cardiometabolic risk factors, predictors of relapse, prediction model, insulin use, long-term outcomes
- MeSH terms
- Adult, Blood Glucose, Diabetes Mellitus, Type 2, Female, Follow-Up Studies, Gastrectomy, Humans, Male, Middle Aged, Prognosis, Recurrence, Retrospective Studies, Time Factors, Gastric Bypass, Weight Loss, Incidence, Treatment Failure, Bariatric Surgery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.